Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States
Topic overview
Multi-institutional study of 34 Fontan patients undergoing combined heart-liver transplantation shows 85% one-year survival, with most procedures performed after 2019. All deaths occurred within 6 months; conditional on hospital discharge, long-term outcomes were excellent and comparable to heart-only transplant recipients.
Comments